Skip to main content

Table 3 Results of multivariable analysis for CSS

From: Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study

  Non-adjusteda Adjust Ib Adjust IIc
HR (95% CI), P value HR (95% CI), P value HR (95% CI), P value
Postoperative capecitabine duration 0.90 (0.84, 0.97), 0.0043 0.90 (0.84, 0.97), 0.0076 0.89 (0.82, 0.96), 0.0035
  0 1.0 1.0 1.0
 ≤ 12 weeks 0.48 (0.24, 0.99), 0.046 0.46 (0.21, 0.98), 0.045 0.37 (0.17, 0.82), 0.015
 ≤ 24 weeks 0.09 (0.01, 0.67), 0.018 0.09 (0.01, 0.69), 0.020 0.07 (0.01, 0.56), 0.012
  1. Notes: aNon-adjusted model adjusted for: none
  2. bAdjust I adjust for: gender; age
  3. cAdjust II adjust for: gender; age; stage; CEA; CA199; CCI; histological type, and MMR status
  4. Abbreviations: HR hazard ratio; CI confidence interval; CA carcinoma antigen; CEA carcinoembryonic antigen; MMR mismatch repair; CCI Charlson comorbidity index